A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets
Condition:   Endometriosis, Uterine Fibroids, Male Hormone-sensitive Prostate Cancer, Assisted Reproduction Interventions:   Drug: SHR7280 tablets;   Drug: SHR7280 dry suspension Sponsor:   Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2023 Category: Research Source Type: clinical trials

AVB-500 (Batiraxcept) in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
Condition:   Recurrent High Grade Uterine Cancer Interventions:   Drug: Paclitaxel;   Drug: Batiraxcept Sponsors:   Washington University School of Medicine;   National Cancer Institute (NCI);   Aravive, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2023 Category: Research Source Type: clinical trials